Showing results (21-30 of 116) with videos related to
Sort By:
Pageof 12
Clinical Lung Cancer|June 14, 2011
A phase II study of carboplatin and irinotecan in extensive stage small-cell lung cancerLeora Horn, Zhiguo Zhao, Alan Sandler, et al.Frontiers in Genetics|April 9, 2026
Single-cell analysis of matched FFPE and frozen tissue samples reveals comparable resolution of intratumoural heterogeneityCathy Yan, Richard D Corbett, Diane Trinh, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 26, 2009
BCL-2 expression is prognostic for improved survival in non-small cell lung cancerDaniel J Renouf, Richard Wood-Baker, Diana N Ionescu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 18, 2012
Thymoma: a population-based study of the management and outcomes for the province of British ColumbiaCaroline Mariano, Diana N Ionescu, Winson Y Cheung, et al.Current Oncology (Toronto, Ont.)|January 20, 2023
Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort StudyRoy Avraham Hilzenrat, Stephen Yip, Barbara Melosky, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
Safety and efficacy of first-line bevacizumab plus chemotherapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer: safety of avastin in lung trial (MO19390)Janessa Laskin, Lucio Crinò, Enriqueta Felip, et al.The American Journal of Surgical Pathology|January 2, 2007
Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significanceDiana N Ionescu, Diana Treaba, Cyril B Gilks, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 28, 2020
Evaluating genomic biomarkers associated with resistance or sensitivity to chemotherapy in patients with advanced breast and colorectal cancerJolene Guenter, Shirin Abadi, Howard Lim, et al.Studies in Health Technology and Informatics|February 8, 2013
The development of a standardized software platform to support provincial population-based cancer outcomes units for multiple tumour sites: OaSIS - Outcomes and Surveillance Integration SystemJonn Wu, Cheryl Ho, Janessa Laskin, et al.JTO Clinical and Research Reports|May 2, 2022
Comparison of 2-Weekly Versus 4-Weekly Durvalumab Consolidation for Locally Advanced NSCLC Treated With Chemoradiotherapy: A Brief ReportMarie-Hélène Denault, Shelley Kuang, Aria Shokoohi, et al.Pageof 12